跳至主要内容
临床试验/EUCTR2004-002535-12-AT
EUCTR2004-002535-12-AT进行中(未招募)1 期

Fluvastatin 80 mg ret. vs combination with ezetimib 10 mg

Clinical Institute of Medical and Chemical Laboratory Diagnostics Graz0 个研究点目标入组 90 人开始时间: 2004年10月15日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
90

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • ·Patients with CHD or CHD equivalent with LDL 100-160 mg/dl
  • ·Male or female sex
  • ·Normal values of CK, AST and ALT
  • ·Normal kidney function
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • ·CHD Stage III-IV
  • ·St. p. myocardial infarction or coronary artery bypass grafting
  • ·Pregnancy or breastfeeding
  • ·AST or ALT > 3x ULN (upper limit of normal)
  • ·CPK > 5x ULN or > 3x with muscle pain, tenderness or weakness
  • ·Severe renal dysfunction, nephritic syndrome
  • ·Premenopausal women without certain contraception
  • ·Known hypersensitivity to HMG-CoA reductase inhibitors or ezetimib

研究者

发起方
Clinical Institute of Medical and Chemical Laboratory Diagnostics Graz

相似试验